Insider Selling: Cardiovascular Systems VP Sells 5,608 Shares of Stock (CSII)
Cardiovascular Systems (NASDAQ:CSII) VP Kevin Kenny sold 5,608 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $27.31, for a total value of $153,154.48. Following the completion of the transaction, the vice president now directly owns 98,418 shares in the company, valued at approximately $2,687,796. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
Several analysts have recently commented on the stock. Analysts at Feltl & Co. raised their price target on shares of Cardiovascular Systems from $27.50 to $32.50 in a research note to investors on Wednesday. They now have a “strong-buy” rating on the stock. Separately, analysts at Dougherty & Co raised their price target on shares of Cardiovascular Systems from $28.00 to $50.00 in a research note to investors on Wednesday. They now have a “buy” rating on the stock. Finally, analysts at Benchmark Co. raised their price target on shares of Cardiovascular Systems from $26.00 to $35.00 in a research note to investors on Tuesday. Three equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $34.70.
Cardiovascular Systems (NASDAQ:CSII) traded up 0.14% on Thursday, hitting $28.88. The stock had a trading volume of 384,958 shares. Cardiovascular Systems has a 52-week low of $10.12 and a 52-week high of $22.84. The stock has a 50-day moving average of $20.71 and a 200-day moving average of $19.78. The company’s market cap is $719.3 million.
Cardiovascular Systems (NASDAQ:CSII) last issued its quarterly earnings data on Wednesday, August 7th. The company reported ($0.28) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.30) by $0.02. The company had revenue of $28.80 million for the quarter, compared to the consensus estimate of $27.18 million. Analysts expect that Cardiovascular Systems will post $-1.19 EPS for the current fiscal year.
Cardiovascular Systems, Inc (NASDAQ:CSII) is a medical device company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.